BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 24803348)

  • 1. Gold(I) N-heterocyclic carbene complexes with naphthalimide ligands as combined thioredoxin reductase inhibitors and DNA intercalators.
    Meyer A; Oehninger L; Geldmacher Y; Alborzinia H; Wölfl S; Sheldrick WS; Ott I
    ChemMedChem; 2014 Aug; 9(8):1794-800. PubMed ID: 24803348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal NHC Complexes with Naphthalimide Ligands as DNA-Interacting Antiproliferative Agents.
    Streciwilk W; Terenzi A; Misgeld R; Frias C; Jones PG; Prokop A; Keppler BK; Ott I
    ChemMedChem; 2017 Feb; 12(3):214-225. PubMed ID: 27997743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold(I) NHC Complexes: Antiproliferative Activity, Cellular Uptake, Inhibition of Mammalian and Bacterial Thioredoxin Reductases, and Gram-Positive Directed Antibacterial Effects.
    Schmidt C; Karge B; Misgeld R; Prokop A; Franke R; Brönstrup M; Ott I
    Chemistry; 2017 Feb; 23(8):1869-1880. PubMed ID: 27865002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
    Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
    J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro evaluation of N-heterocyclic carbene gold(I) complexes of the benzimidazolylidene type.
    Rubbiani R; Can S; Kitanovic I; Alborzinia H; Stefanopoulou M; Kokoschka M; Mönchgesang S; Sheldrick WS; Wölfl S; Ott I
    J Med Chem; 2011 Dec; 54(24):8646-57. PubMed ID: 22039997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic gold(I) N-heterocyclic carbene complexes with phosphane ligands as potent enzyme inhibitors.
    Rubbiani R; Salassa L; de Almeida A; Casini A; Ott I
    ChemMedChem; 2014 Jun; 9(6):1205-10. PubMed ID: 24677779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cobaltoceniumethynyl gold(I) as an unusual heterodinuclear bioorganometallic fragment to study the biological properties of alkynyl gold complexes.
    Vanicek S; Kopacka H; Wurst K; Vergeiner S; Kankowski S; Schur J; Bildstein B; Ott I
    Dalton Trans; 2016 Jan; 45(4):1345-8. PubMed ID: 26732365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents.
    Schuh E; Pflüger C; Citta A; Folda A; Rigobello MP; Bindoli A; Casini A; Mohr F
    J Med Chem; 2012 Jun; 55(11):5518-28. PubMed ID: 22621714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl
    Truong D; Sullivan MP; Tong KKH; Steel TR; Prause A; Lovett JH; Andersen JW; Jamieson SMF; Harris HH; Ott I; Weekley CM; Hummitzsch K; Söhnel T; Hanif M; Metzler-Nolte N; Goldstone DC; Hartinger CG
    Inorg Chem; 2020 Mar; 59(5):3281-3289. PubMed ID: 32073260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold(I) thiotetrazolates as thioredoxin reductase inhibitors and antiproliferative agents.
    Serebryanskaya TV; Lyakhov AS; Ivashkevich LS; Schur J; Frias C; Prokop A; Ott I
    Dalton Trans; 2015 Jan; 44(3):1161-9. PubMed ID: 25413270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of Titanocene-Gold Compounds Based on Highly Active Gold(I)-N-Heterocyclic Carbene Anticancer Agents: Preliminary in vitro Studies in Renal and Prostate Cancer Cell Lines.
    Curado N; Giménez N; Miachin K; Aliaga-Lavrijsen M; Cornejo MA; Jarzecki AA; Contel M
    ChemMedChem; 2019 Jun; 14(11):1086-1095. PubMed ID: 30924298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches.
    Karaca Ö; Scalcon V; Meier-Menches SM; Bonsignore R; Brouwer JMJL; Tonolo F; Folda A; Rigobello MP; Kühn FE; Casini A
    Inorg Chem; 2017 Nov; 56(22):14237-14250. PubMed ID: 29095609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols.
    Hickey JL; Ruhayel RA; Barnard PJ; Baker MV; Berners-Price SJ; Filipovska A
    J Am Chem Soc; 2008 Sep; 130(38):12570-1. PubMed ID: 18729360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NHC gold halide complexes derived from 4,5-diarylimidazoles: synthesis, structural analysis, and pharmacological investigations as potential antitumor agents.
    Liu W; Bensdorf K; Proetto M; Abram U; Hagenbach A; Gust R
    J Med Chem; 2011 Dec; 54(24):8605-15. PubMed ID: 22091836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic and Neutral N-Heterocyclic Carbene Gold(I) Complexes: Cytotoxicity, NCI-60 Screening, Cellular Uptake, Inhibition of Mammalian Thioredoxin Reductase, and Reactive Oxygen Species Formation.
    Zhang C; Hemmert C; Gornitzka H; Cuvillier O; Zhang M; Sun RW
    ChemMedChem; 2018 Jun; 13(12):1218-1229. PubMed ID: 29603648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of ester- and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes.
    Pellei M; Gandin V; Marinelli M; Marzano C; Yousufuddin M; Dias HV; Santini C
    Inorg Chem; 2012 Sep; 51(18):9873-82. PubMed ID: 22946642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents.
    Messori L; Marchetti L; Massai L; Scaletti F; Guerri A; Landini I; Nobili S; Perrone G; Mini E; Leoni P; Pasquali M; Gabbiani C
    Inorg Chem; 2014 Mar; 53(5):2396-403. PubMed ID: 24547701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gold(I) and Gold(III) N-Heterocyclic Carbene Complexes as Antibacterial Agents and Inhibitors of Bacterial Thioredoxin Reductase.
    Büssing R; Karge B; Lippmann P; Jones PG; Brönstrup M; Ott I
    ChemMedChem; 2021 Nov; 16(22):3402-3409. PubMed ID: 34268875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescent organometallic rhodium(I) and ruthenium(II) metallodrugs with 4-ethylthio-1,8-naphthalimide ligands: Antiproliferative effects, cellular uptake and DNA-interaction.
    Streciwilk W; Terenzi A; Cheng X; Hager L; Dabiri Y; Prochnow P; Bandow JE; Wölfl S; Keppler BK; Ott I
    Eur J Med Chem; 2018 Aug; 156():148-161. PubMed ID: 30006161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of arene ruthenium(II) N-heterocyclic carbene complexes as organometallics interacting with thiol and selenol containing biomolecules.
    Oehninger L; Stefanopoulou M; Alborzinia H; Schur J; Ludewig S; Namikawa K; Muñoz-Castro A; Köster RW; Baumann K; Wölfl S; Sheldrick WS; Ott I
    Dalton Trans; 2013 Feb; 42(5):1657-66. PubMed ID: 23149817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.